TUGALTO Trademark

Trademark Overview


On Friday, February 25, 2022, a trademark application was filed for TUGALTO with the United States Patent and Trademark Office. The USPTO has given the TUGALTO trademark a serial number of 79337833. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, March 21, 2024. This trademark is owned by NOVARTIS AG. The TUGALTO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
tugalto

General Information


Serial Number79337833
Word MarkTUGALTO
Filing DateFriday, February 25, 2022
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, March 21, 2024
Registration Number6882146
Registration DateTuesday, October 25, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2022

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, March 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, April 18, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 7, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, April 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 26, 2022APPLICATION FILING RECEIPT MAILED
Monday, June 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 20, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, June 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 5, 2022ASSIGNED TO EXAMINER
Tuesday, July 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 6, 2022FINAL DISPOSITION PROCESSED
Tuesday, October 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, November 24, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, October 16, 2024DEATH OF INTERNATIONAL REGISTRATION
Wednesday, October 16, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, December 26, 2022NOTIFICATION PROCESSED BY IB
Tuesday, December 6, 2022FINAL DISPOSITION NOTICE SENT TO IB